UCB SA (UCB.BR)

EUR 169.2

(5.0%)

Inventory Summary of UCB SA

UCB SA's latest annual inventory in 2023 was 1.03 Billion EUR , up 13.67% from previous year.
UCB SA's latest quarterly inventory in 2024 Q2 was 1.13 Billion EUR , down 0.0% from previous quarter.
UCB SA reported annual inventory of 907 Million EUR in 2022, up 3.3% from previous year.
UCB SA reported annual inventory of 878 Million EUR in 2021, up 2.81% from previous year.
UCB SA reported quarterly inventory of 1.03 Billion EUR for 2023 FY, up 13.67% from previous quarter.
UCB SA reported quarterly inventory of 912 Million EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Inventory Chart of UCB SA (2023 - 2002)

Historical Annual Inventory of UCB SA (2023 - 2002)

Year	Inventory	Inventory Growth
2023	1.03 Billion EUR	13.67%
2022	907 Million EUR	3.3%
2021	878 Million EUR	2.81%
2020	854 Million EUR	9.49%
2019	780 Million EUR	20.56%
2018	647 Million EUR	8.38%
2017	597 Million EUR	3.29%
2016	578 Million EUR	2.12%
2015	566 Million EUR	3.47%
2014	547 Million EUR	-12.76%
2013	627 Million EUR	1.79%
2012	616 Million EUR	14.71%
2011	537 Million EUR	23.73%
2010	434 Million EUR	7.16%
2009	405 Million EUR	11.57%
2008	363 Million EUR	18.24%
2007	307 Million EUR	-28.94%
2006	432 Million EUR	65.52%
2005	261 Million EUR	-30.78%
2004	377.05 Million EUR	-6.66%
2003	403.94 Million EUR	-47.77%
2002	773.43 Million EUR	0.0%

Year	Inventory	Inventory Growth
2024 Q2	1.13 Billion EUR	0.0%
2023 FY	1.03 Billion EUR	13.67%
2023 Q2	912 Million EUR	0.0%
2023 Q4	1.03 Billion EUR	0.0%
2022 FY	907 Million EUR	3.3%
2022 Q2	861 Million EUR	0.0%
2022 Q4	907 Million EUR	0.0%
2021 Q2	894 Million EUR	0.0%
2021 Q4	878 Million EUR	0.0%
2021 FY	878 Million EUR	2.81%
2020 Q4	854 Million EUR	0.0%
2020 Q2	825 Million EUR	0.0%
2020 FY	854 Million EUR	9.49%
2019 Q4	780 Million EUR	0.0%
2019 FY	780 Million EUR	20.56%
2019 Q2	706 Million EUR	0.0%
2018 Q4	647 Million EUR	0.0%
2018 FY	647 Million EUR	8.38%
2018 Q2	632 Million EUR	0.0%
2017 FY	597 Million EUR	3.29%
2017 Q2	610 Million EUR	0.0%
2017 Q4	597 Million EUR	0.0%
2016 Q4	578 Million EUR	0.0%
2016 FY	578 Million EUR	2.12%
2016 Q2	589 Million EUR	0.0%
2015 Q4	566 Million EUR	0.0%
2015 Q2	570 Million EUR	0.0%
2015 FY	566 Million EUR	3.47%
2014 Q2	625 Million EUR	0.0%
2014 FY	547 Million EUR	-12.76%
2014 Q4	547 Million EUR	0.0%
2013 Q4	627 Million EUR	0.0%
2013 FY	627 Million EUR	1.79%
2013 Q2	647 Million EUR	0.0%
2012 Q2	600 Million EUR	0.0%
2012 FY	616 Million EUR	14.71%
2012 Q4	616 Million EUR	0.0%
2011 Q4	537 Million EUR	0.0%
2011 Q2	436 Million EUR	0.0%
2011 FY	537 Million EUR	23.73%
2010 FY	434 Million EUR	7.16%
2010 Q4	434 Million EUR	0.0%
2010 Q2	412 Million EUR	0.0%
2009 Q4	405 Million EUR	0.0%
2009 FY	405 Million EUR	11.57%
2008 FY	363 Million EUR	18.24%
2007 FY	307 Million EUR	-28.94%
2006 FY	432 Million EUR	65.52%
2005 FY	261 Million EUR	-30.78%
2004 FY	377.05 Million EUR	-6.66%
2003 FY	403.94 Million EUR	-47.77%
2002 FY	773.43 Million EUR	0.0%

Peer Inventory Comparison of UCB SA

Name	Inventory	Inventory Difference
Nicox S.A.	- EUR	-Infinity%
European Medical Solutions	14.35 Million EUR	-7080.666%
FERMENTALG	6.8 Million EUR	-15048.398%
argenx SE	281.12 Million EUR	-266.735%
BioSenic S.A.	- EUR	-Infinity%
Celyad Oncology SA	1.26 Million EUR	-81725.397%
Hyloris Pharmaceuticals SA	1.00 EUR	-103099999900.0%
Onward Medical N.V.	936 Thousand EUR	-110049.573%
Oxurion NV	128 Thousand EUR	-805368.75%
PHAXIAM Therapeutics S.A.	671 Thousand EUR	-153551.267%
Financière de Tubize SA	- EUR	-Infinity%